Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INSP Inspire Medical Systems	$95.80 +4.6%	$117.55	$73.92 ▼ $225.00	$2.84B	1.22	1.66 million shs	559,798 shs
LQDA Liquidia Technologies	$26.84 -1.7%	$17.51	$8.75 ▼ $28.00	$2.31B	0.14	3.26 million shs	2.60 million shs
WEDXF Westaim	$20.80 +0.3%	$22.01	$16.62 ▼ $25.98	$697.94M	0.23	2,780 shs	5,263 shs
WRBY Warby Parker	$27.02 +3.6%	$23.53	$12.69 ▼ $29.73	$2.84B	2.09	1.88 million shs	1.10 million shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INSP Inspire Medical Systems	0.00%	+9.27%	-25.47%	-33.12%	-48.86%
LQDA Liquidia Technologies	0.00%	+3.43%	+42.99%	+74.85%	+168.94%
WEDXF Westaim	0.00%	-3.03%	-3.70%	-7.92%	+612.33%
WRBY Warby Parker	0.00%	-0.81%	+10.98%	+36.18%	+92.44%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INSP Inspire Medical Systems	4.9388 of 5 stars	4.3	4.0	4.8	4.0	1.7	1.9
LQDA Liquidia Technologies	3.4102 of 5 stars	3.5	3.0	0.0	2.4	4.2	0.6
WEDXF Westaim	1.1597 of 5 stars	0.0	5.0	0.0	2.8	0.0	0.6
WRBY Warby Parker	2.2444 of 5 stars	2.3	2.0	0.0	3.7	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INSP Inspire Medical Systems	2.54	Moderate Buy	$165.62	72.88% Upside
LQDA Liquidia Technologies	3.00	Buy	$32.11	19.64% Upside
WEDXF Westaim	0.00	N/A	N/A	N/A
WRBY Warby Parker	2.58	Moderate Buy	$24.06	-10.94% Downside

Current Analyst Ratings Breakdown

Latest WEDXF, WRBY, INSP, and LQDA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	INSP Inspire Medical Systems	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$116.00 ➝ $97.00
8/15/2025	LQDA Liquidia Technologies	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$43.00
8/13/2025	LQDA Liquidia Technologies	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Strong-Buy ➝ Strong-Buy	$33.00 ➝ $41.00
8/13/2025	LQDA Liquidia Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$25.00 ➝ $31.00
8/12/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $36.00
8/8/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	WRBY Warby Parker	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$20.00 ➝ $23.00
8/8/2025	WRBY Warby Parker	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$21.00 ➝ $22.00
8/7/2025	WRBY Warby Parker	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive
8/7/2025	WRBY Warby Parker	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$28.00
8/7/2025	WRBY Warby Parker	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $28.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INSP Inspire Medical Systems	$802.80M	3.53	$1.71 per share	56.18	$22.92 per share	4.18
LQDA Liquidia Technologies	$14M	165.05	N/A	N/A	$0.18 per share	149.11
WEDXF Westaim	$17.04M	40.97	N/A	N/A	$23.28 per share	0.89
WRBY Warby Parker	$771.32M	3.68	$0.34 per share	79.59	$3.44 per share	7.85

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INSP Inspire Medical Systems	$53.51M	$1.73	55.37	29.75	2.99	6.17%	10.38%	8.93%	11/3/2025 (Estimated)
LQDA Liquidia Technologies	-$130.39M	-$1.70	N/A	N/A	N/A	-732.17%	-232.96%	-60.81%	11/12/2025 (Estimated)
WEDXF Westaim	-$16.18M	-$1.40	N/A	∞	N/A	-118.02%	-6.03%	-5.73%	11/11/2025 (Estimated)
WRBY Warby Parker	-$20.39M	-$0.07	N/A	270.18	N/A	-1.12%	-0.79%	-0.41%	11/6/2025 (Estimated)

Latest WEDXF, WRBY, INSP, and LQDA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/21/2025	Q2 2025	WEDXF Westaim	-$0.17	-$0.01	+$0.16	-$0.01	$1.46 million	$10.50 million
8/12/2025	Q2 2025	LQDA Liquidia Technologies	-$0.43	-$0.49	-$0.06	-$0.49	$3.90 million	$8.84 million
8/4/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	$0.45	+$0.23	-$0.12	$214.50 million	$217.09 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LQDA Liquidia Technologies	N/A	N/A	N/A	N/A	N/A
WEDXF Westaim	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INSP Inspire Medical Systems	N/A	6.14	4.84
LQDA Liquidia Technologies	9.84	2.49	2.41
WEDXF Westaim	N/A	11.40	11.40
WRBY Warby Parker	N/A	2.55	2.23

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INSP Inspire Medical Systems	94.91%
LQDA Liquidia Technologies	64.54%
WEDXF Westaim	N/A
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
INSP Inspire Medical Systems	4.10%
LQDA Liquidia Technologies	26.50%
WEDXF Westaim	4.21%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INSP Inspire Medical Systems	1,246	29.57 million	28.36 million	Optionable
LQDA Liquidia Technologies	50	86.09 million	63.28 million	Optionable
WEDXF Westaim	7	33.56 million	32.14 million	Not Optionable
WRBY Warby Parker	3,780	105.19 million	86.00 million	Optionable

WEDXF, WRBY, INSP, and LQDA Headlines

Recent News About These Companies

16,600 Shares in Warby Parker Inc. $WRBY Bought by Versor Investments LP

August 24 at 4:50 AM | marketbeat.com

Warby Parker (NYSE:WRBY) Raised to Buy at Wall Street Zen

August 24 at 2:22 AM | americanbankingnews.com

EntryPoint Capital LLC Acquires New Shares in Warby Parker Inc. $WRBY

August 23 at 6:21 AM | marketbeat.com

American Century Companies Inc. Has $44.79 Million Stock Position in Warby Parker Inc. $WRBY

August 23 at 4:43 AM | marketbeat.com

Vanguard Group Inc. Has $176.82 Million Holdings in Warby Parker Inc. $WRBY

August 22 at 3:18 AM | marketbeat.com

Northwest & Ethical Investments L.P. Cuts Stake in Warby Parker Inc. $WRBY

August 21 at 4:43 AM | marketbeat.com

Cetera Investment Advisers Makes New $319,000 Investment in Warby Parker Inc. $WRBY

August 21 at 3:08 AM | marketbeat.com

Fox Run Management L.L.C. Makes New $552,000 Investment in Warby Parker Inc. $WRBY

August 20, 2025 | marketbeat.com

Lord Abbett & CO. LLC Has $6.58 Million Position in Warby Parker Inc. (NYSE:WRBY)

August 19, 2025 | marketbeat.com

1,675,768 Shares in Warby Parker Inc. (NYSE:WRBY) Purchased by Nuveen LLC

August 19, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Stock Position Decreased by Deutsche Bank AG

August 18, 2025 | marketbeat.com

Aigen Investment Management LP Takes Position in Warby Parker Inc. (NYSE:WRBY)

August 16, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Director Sells $141,360.00 in Stock

August 15, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 50,000 Shares

August 15, 2025 | marketbeat.com

Stocks Showing Market Leadership: Warby Parker Earns 93 RS Rating

August 14, 2025 | msn.com

Warby Parker CFO Steve Miller Resigns

August 14, 2025 | theglobeandmail.com

Telsey Advisory Sticks to Its Buy Rating for Warby Parker (WRBY)

August 14, 2025 | theglobeandmail.com

The 5 Most Interesting Analyst Questions From Warby Parker’s Q2 Earnings Call

August 14, 2025 | finance.yahoo.com

Teresa Briggs Sells 6,000 Shares of Warby Parker Inc. (NYSE:WRBY) Stock

August 14, 2025 | insidertrades.com

Connor Clark & Lunn Investment Management Ltd. Has $5.09 Million Position in Warby Parker Inc. (NYSE:WRBY)

August 14, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Position Trimmed by AIA Group Ltd

August 13, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WEDXF, WRBY, INSP, and LQDA Company Descriptions

Inspire Medical Systems NYSE:INSP

$95.80 +4.18 (+4.56%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$96.01 +0.21 (+0.22%)

As of 08/22/2025 07:41 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Liquidia Technologies NASDAQ:LQDA

$26.84 -0.46 (-1.68%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$26.92 +0.09 (+0.32%)

As of 08/22/2025 07:52 PM Eastern

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Westaim OTCMKTS:WEDXF

$20.80 +0.06 (+0.27%)

As of 08/22/2025 03:26 PM Eastern

The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.

Warby Parker NYSE:WRBY

$27.02 +0.95 (+3.64%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$27.08 +0.06 (+0.21%)

As of 08/22/2025 05:52 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time